A head-to-head study comparing five serological assays for SARS-CoV-2 antibodies showed that a commercial immunoassay by Siemens and a novel ELISA* test developed by the University of Oxford could achieve the desired sensitivity and specificity without further optimization — providing reassurance for their use.
A systematic review of randomized controlled trials (RCTs) has confirmed the potential of remdesivir in improving recovery and reducing serious adverse events (AEs), as well as mortality and time to clinical improvement, but not hospital length of stay, in coronavirus disease (COVID-19) patients.
Amid the pandemic of the novel coronavirus disease (COVID-19), healthcare workers in Asia are suffering from high rates of psychological distress, according to a recent study. The rates vary greatly across countries and seem to be independent of the case burden.
Hospitalized COVID-19 patients with prolonged fever showed more pronounced inflammatory response and were more likely to require ICU admission than cases with saddleback fever or with fever lasting ≤7 days, a Singapore study reveals.
Levels of depression, anxiety, and stress among antenatal women increase due to a lack of timely and reliable information on the impact of the novel coronavirus disease (COVID-19) on pregnancy and its outcomes, according to a Singapore study.
When dealing with a dual outbreak of dengue and the novel coronavirus disease (COVID-19), a strong triage system, including designated testing wards and diagnostic tests, can help minimize the risk of healthcare-associated transmission, according to a new Singapore study.
Application for Sputnik V, the tradename of the world’s first registered COVID-19 vaccine, has been submitted to the WHO for accelerated registration via the Emergency Use Listing (EUL) and prequalification.